Cravihenz 40 mg Tablet belongs to a class of medications called ‘Progestogens’ used as a symptomatic treatment in patients with breast cancer and endometrial cancer. Breast cancer develops in cells of the breast cells characterized by a lump in the breast, a change in the shape of the nipple or breast, and bloody discharge from the nipples. Endometrial cancer is the cancer of the womb's lining (uterus), characterized by pelvic pain, bleeding between periods, and pain during sex.

Cravihenz 40 mg Tablet contains ‘Megestrol’, which belongs to the class of ‘Progestogens’. It works similarly to the female hormone ‘progesterone’. It interferes with the production or action of hormones involved in cancer growth. This effect helps to slow down the progression of cancer and reduce the symptoms associated with cancer.

Cravihenz 40 mg Tablet is available in the form of a tablet and oral suspension. You should take this medicine exactly as prescribed by your doctor. The common side-effects of Cravihenz 40 mg Tablet are an increase in appetite, weight gain, shortness of breath, hot flushes (reddening of the face and neck), high blood pressure, increased blood sugar levels, rounded face, constipation, and swelling of a vein due to a blood clot. If any of these side effects persist or get worse, inform your doctor immediately.

Do not take Cravihenz 40 mg Tablet if allergic to Megestrol or any contents. Before taking Cravihenz 40 mg Tablet , inform your doctor if you have severe liver problems, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorder, and diabetes. Cravihenz 40 mg Tablet should be used with caution in elderly patients. Cravihenz 40 mg Tablet is not recommended for children, pregnant women, and breastfeeding mothers. Do not consume alcohol, as it may increase the risk of side effects. Cravihenz 40 mg Tablet may not affect your ability to drive.

Cravihenz 40 mg Tablet contains ‘Megestrol’, which is used in the treatment of breast cancer and endometrial cancer. It acts by interfering with the production of hormones that cause the development of cancer. It helps to reduce the symptoms of cancer effectively. It can also be used to treat loss of appetite in patients with HIV/AIDS.

Cravihenz 40 mg Tablet increases the risk of blood clots, so it should be used cautiously in patients with a history of thrombophlebitis. Also, if you notice impaired coordination, difficulty speaking, pain in the groin, pain in the arm or leg (especially in the calf of the leg), shortness of breath, general weakness, headache, and dizziness, inform your doctor immediately as it may be a sign of blood clot. Cravihenz 40 mg Tablet is not recommended for use in pregnancy. Use a reliable contraceptive method to prevent pregnancy while using this medicine. You may also need to take a pregnancy test before using this medicine. Cravihenz 40 mg Tablet contains lactose, so inform your doctor if you have an intolerance to any sugars.

• If you are undergoing surgery, inform your doctor that you are taking Cravihenz 40 mg Tablet as it may interfere with the healing process.
• Please do not stop taking Cravihenz 40 mg Tablet without discussing it with your doctor.
• Your doctor may advise you to monitor blood pressure regularly and take blood tests to evaluate liver and kidney function while using Cravihenz 40 mg Tablet .